A diabetes medicine poised to win Food and Drug Administration approval sharply increases the risk of heart problems, strokes and death, researchers reported yesterday in an analysis that raises new questions about how the agency handles drug safety concerns. -
New Diabetes Drug Poses Major Risks, Panel Says
A diabetes medicine poised to win Food and Drug Administration approval sharply increases the risk of heart problems, strokes and death, researchers reported yesterday in an analysis that raises new questions about how the agency handles drug safety concerns.-
By Rob Stein and Marc Kaufman